ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ALNY Alnylam Pharmaceuticals Inc

143.31
-0.40 (-0.28%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Alnylam Pharmaceuticals Inc ALNY NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.40 -0.28% 143.31 06:30:00
始値 安値 高値 終値 前日終値
144.08 143.00 146.065 143.31 143.71
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1821:00BWAlnylam to Webcast Conference Call Discussing First Quarter..
2024/4/0721:00BWAlnylam Presents Positive Results from the KARDIA-2 Phase 2..
2024/3/2021:00BWAlnylam to Webcast Investor Event to Discuss Results from..
2024/3/1320:30BWAlnylam Launches Hereditary ATTR (hATTR) Amyloidosis..
2024/3/0620:50BWAlnylam meldet positive KARDIA-2 Topline-Studienergebnisse,..
2024/3/0607:39BWAlnylam annonce des résultats positifs de l’étude KARDIA-2..
2024/3/0606:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0521:30BWAlnylam Reports Positive KARDIA-2 Topline Study Results..
2024/3/0506:33EDGAR2Form 8-K - Current report
2024/3/0106:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:00EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2722:30BWAlnylam to Webcast Presentations at Upcoming March Investor..
2024/2/2106:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1606:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1522:10EDGAR2Form 8-K - Current report
2024/2/1522:00BWAlnylam Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/2/1008:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2922:00BWAlnylam to Webcast Conference Call Discussing Fourth Quarter..
2024/1/2006:31EDGAR2Form 8-K - Current report
2024/1/0922:05BWAlnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year..
2024/1/0821:00EDGAR2Form 8-K - Current report
2024/1/0808:00BWAlnylam Announces Preliminary* Fourth Quarter and Full Year..
2024/1/0221:30BWAlnylam to Webcast Presentation at 42nd Annual J.P. Morgan..
2023/12/3006:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2806:03EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1321:30BWAlnylam Highlights Significant Progress with Platform..
2023/12/1206:07EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0622:00BWAlnylam to Webcast Virtual R&D Day
2023/11/3022:00BWAlnylam Ranks #1 on Boston Globe’s Top Places to Work List..
2023/11/1302:08BWAlnylam présente des résultats positifs de l'étude KARDIA-1..
2023/11/1206:00BWAlnylam Presents Positive Results from the KARDIA-1 Phase 2..
2023/11/0722:00BWAlnylam to Webcast Presentations at Upcoming November..
2023/11/0221:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0221:10EDGAR2Form 8-K - Current report
2023/11/0221:00BWAlnylam Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/10/2703:00BWAlnylam Recognized by Science Magazine as Top Employer for..
2023/10/2606:19BWAlnylam Announces Publication of Results from APOLLO-B Phase..
2023/10/2600:05BWAlnylam Reports Additional Positive Interim Phase 1 Results..
2023/10/1921:00BWAlnylam to Webcast Conference Call Discussing Third Quarter..
2023/10/1020:30EDGAR2Form 8-K - Current report
2023/10/1020:02IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations

最近閲覧した銘柄

Delayed Upgrade Clock